Virxsys Corporation

Gaithersburg, MD 20877

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $1.63MM
First Award Date 08/15/02
Most Recent Award Date 04/01/06

Key Personnel

Last Name Name Awards Contact
Dropulic Boro Dropulic 2
Humeau Laurent Michel Humeau 1
Lu Xiaobin Lu 1

4 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/06 - 03/31/07

DESCRIPTION (provided by applicant): HIV infects 40 million people worldwide. In the United States (U.S.), it is estimated that almost one million people are infected with HIV. The mortality due to HIV/AIDS is estimated to be approximately three (3) million deaths annually worldwide, with 15,000 deaths per year in the U.S. The current standard ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/05 - 03/31/06

DESCRIPTION (provided by applicant): HIV infects 40 million people worldwide. In the United States (U.S.), it is estimated that almost one million people are infected with HIV. The mortality due to HIV/AIDS is estimated to be approximately three (3) million deaths annually worldwide, with 15,000 deaths per year in the U.S. The current standard ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/04 - 03/31/05

DESCRIPTION (provided by applicant): HIV infects 40 million people worldwide. In the United States (U.S.), it is estimated that almost one million people are infected with HIV. The mortality due to HIV/AIDS is estimated to be approximately three (3) million deaths annually worldwide, with 15,000 deaths per year in the U.S. The current standard ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/15/02 - 02/14/04

DESCRIPTION (Provided by the applicant): The long-term goal of this study is to determine whether HIV-I based vectors can prevent AIDS disease progression in HIV-infected individuals. We have shown that an HIV vector carrying an anti-HIV antisense genetic payload (VRX496) can transduce primary human CD4 T cells by over 90 percent transduction ef...